RARRES2 and metabolic dysfunction-associated steatohepatitis: Moreover, in the NASH-related HCC mouse model, chemerin expression and receptor activation remain unchanged between tumor-bearing and control groups, despite the presence of liver tumors suggesting that high endogenous chemerin is not sufficient to prevent hepatocarcinogenesis [73].